Although the majority of results are associated to neuropsychiatric disorders, our enrichment analysis suggests an interaction between MeCP2 and neurological conditions such as Alzheimer disease, multiple sclerosis and epilepsy. This evidence concerns the gene MECP2 and epilepsy.